Ionis Pharmaceuticals, Inc. (IONS)

Ionis Pharmaceuticals Revenue

Ionis Pharmaceuticals had revenue of $452.05M in the quarter ending June 30, 2025, with 100.69% growth. This brings the company's revenue in the last twelve months to $944.05M, up 16.05% year-over-year. In the year 2024, Ionis Pharmaceuticals had annual revenue of $705.14M, down -10.48%.

• Revenue (ttm): $944.05M
• Revenue Growth: +16.05%
• P/S Ratio: 10.59
• Revenue / Employee: $883,115
• Employees: 1,069
• Market Cap: 10.21B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	705.14M	-82.51M	-10.48%
Dec 31, 2023	787.65M	200.28M	34.10%
Dec 31, 2022	587.37M	-223.09M	-27.53%
Dec 31, 2021	810.46M	81.19M	11.13%
Dec 31, 2020	729.26M	-393.34M	-35.04%

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.